Literature DB >> 7902361

P-glycoprotein (MDR 1 gene product) in cells of the immune system: its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection.

S Gupta1, S Gollapudi.   

Abstract

P-glycoprotein, a 170-kd glycoprotein encoded by the MDR 1 gene, is a member of a highly conserved superfamily of ATP-binding cassette (ABC) transport proteins. It shares extensive homology with numerous bacterial and eukaryotic ABC transport proteins. P-glycoprotein acts as an energy-dependent efflux pump that appears to transport structurally diverse agents ranging from ions to peptides. P-glycoprotein (P-gP) has been implicated as playing a role in multidrug (MDR) resistance in cancer, chloroquine-resistant Plasmodium falciparum infection, and possibly human immunodeficiency virus-1 (HIV-1) resistance to nucleoside compounds. A number of normal tissues in humans and rodents have been shown to express high levels of P-gp. The expression and function of P-gp in cells of the immune system have been explored in the past 2 years. This review presents a state of the art regarding the expression, regulation, and function of Pgp in cells of the immune system. In addition, its alteration in aging and HIV-1 infection is reviewed. A possible physiologic role of P-gp in cytokine secretion, antigen processing/presentation, and effector functions is also discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902361     DOI: 10.1007/bf00920237

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  59 in total

Review 1.  P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.

Authors:  D Nielsen; T Skovsgaard
Journal:  Biochim Biophys Acta       Date:  1992-07-07

2.  Peptide transport by the multidrug resistance pump.

Authors:  R C Sharma; S Inoue; J Roitelman; R T Schimke; R D Simoni
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

3.  Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.

Authors:  S Yanovich; R E Hall; C Weinert
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

Review 4.  Resistance of multidrug-resistant lines to natural killer-like cell-mediated cytotoxicity.

Authors:  G Woods; L A Lund; M Naik; V Ling; A Ochi
Journal:  FASEB J       Date:  1988-09       Impact factor: 5.191

5.  Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein.

Authors:  B M Foxwell; A Mackie; V Ling; B Ryffel
Journal:  Mol Pharmacol       Date:  1989-10       Impact factor: 4.436

6.  Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors.

Authors:  R G Andrews; J W Singer; I D Bernstein
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

7.  Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance.

Authors:  N Kartner; J W Hanrahan; T J Jensen; A L Naismith; S Z Sun; C A Ackerley; E F Reyes; L C Tsui; J M Rommens; C E Bear
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

8.  Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (suppressor inducer) population.

Authors:  P De Paoli; S Battistin; G F Santini
Journal:  Clin Immunol Immunopathol       Date:  1988-09

9.  The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin.

Authors:  I A de Lannoy; M Silverman
Journal:  Biochem Biophys Res Commun       Date:  1992-11-30       Impact factor: 3.575

10.  Human immunodeficiency virus I-induced expression of P-glycoprotein.

Authors:  S Gollapudi; S Gupta
Journal:  Biochem Biophys Res Commun       Date:  1990-09-28       Impact factor: 3.575

View more
  17 in total

Review 1.  P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

Authors:  Sanjay U C Sankatsing; Jos H Beijnen; Alfred H Schinkel; Joep M A Lange; Jan M Prins
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

Review 2.  Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

Authors:  Minlu Hu; Sravan Kumar Patel; Tian Zhou; Lisa C Rohan
Journal:  J Control Release       Date:  2015-08-13       Impact factor: 9.776

3.  Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival.

Authors:  S Gollapud; S Gupta
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

4.  P-glycoprotein and alloimmune T-cell activation.

Authors:  Shona S Pendse; David M Briscoe; Markus H Frank
Journal:  Clin Appl Immunol Rev       Date:  2003-07

5.  HIV/AIDS patients display lower relative bioavailability of efavirenz than healthy subjects.

Authors:  Jackson K Mukonzo; Sarah Nanzigu; Dinko Rekić; Paul Waako; Daniel Röshammar; Michael Ashton; Jasper Ogwal-Okeng; Lars L Gustafsson; Eleni Aklillu
Journal:  Clin Pharmacokinet       Date:  2011-08       Impact factor: 6.447

6.  Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans.

Authors:  S Aggarwal; T Tsuruo; S Gupta
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

7.  Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporine A analogs.

Authors:  W T Klimecki; C W Taylor; W S Dalton
Journal:  J Clin Immunol       Date:  1995-05       Impact factor: 8.317

8.  The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis.

Authors:  M J Smyth; E Krasovskis; V R Sutton; R W Johnstone
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

Review 9.  P-glycoprotein expression and regulation. Age-related changes and potential effects on drug therapy.

Authors:  S Gupta
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

Review 10.  Intracellular phosphorylation of zidovudine (ZDV) and other nucleoside reverse transcriptase inhibitors (RTI) used for human immunodeficiency virus (HIV) infection.

Authors:  K Peter; J G Gambertoglio
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.